EMBRYO-FETAL TOXICITY
See full prescribing information for complete boxed warning.
- TRADE NAME: Adempas (Bayer)
- INDICATIONS: Pulmonary hypertension
- CLASS: Soluble guanylate cyclase (sGC) stimulator
- HALF-LIFE: 7–12 hours
- FDA APPROVAL DATE: 10/08/2013
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Antacids, Carbamazepine, Dipyridamole, Nitrates or nitric oxide donors, Nitroprusside, Phenobarbital, Phenytoin, Rifampin, Sildenafil, St John's Wort, Tadalafil, Theophylline, Vardenafil
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
